The Procter & Gamble Company Restructuring Reserve, Settled without Cash
The Procter & Gamble Company (PG) reported Restructuring Reserve, Settled without Cash of $372.00 million for the 12-month period ending 2020-06-30, per its 10-K/A filed 2020-08-07.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2020-08-07
- The Procter & Gamble Company restructuring reserve, settled without cash for the quarter ending 2020-06-30 was $151.00M, a 0.67% increase year-over-year.
- The Procter & Gamble Company restructuring reserve, settled without cash for the quarter ending 2020-03-31 was $148.00M, a 184.62% increase year-over-year.
- The Procter & Gamble Company restructuring reserve, settled without cash for the quarter ending 2019-12-31 was $28.00M, a 27.27% increase year-over-year.
- The Procter & Gamble Company restructuring reserve, settled without cash for the quarter ending 2019-09-30 was $45.00M, a 60.71% increase year-over-year.
- The Procter & Gamble Company restructuring reserve, settled without cash for fiscal 2020 was $372.00M, a 47.62% increase from fiscal 2019.
- The Procter & Gamble Company restructuring reserve, settled without cash for fiscal 2019 was $252.00M, a 31.15% decline from fiscal 2018.
- The Procter & Gamble Company restructuring reserve, settled without cash for fiscal 2018 was $366.00M.
- The Procter & Gamble Company restructuring reserve, settled without cash for fiscal 2016 was $432.00M.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 6 month | Restructuring Reserve, Settled without Cash 9 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|---|---|
| 2020-06-30 | $151.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $299.00M derived: sum of 2 quarters · filed 2020-08-07 | $327.00M derived: sum of 3 quarters · filed 2020-08-07 | $372.00M 10-K/A · filed 2020-08-07 |
| 2020-03-31 | $148.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-20 | $176.00M derived: sum of 2 quarters · filed 2020-04-20 | $221.00M 10-Q · filed 2020-04-20 | $371.00M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-12-31 | $28.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-23 | $73.00M 10-Q · filed 2020-01-23 | $223.00M derived: sum of 3 quarters · filed 2020-08-07 | $275.00M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-09-30 | $45.00M 10-Q · filed 2019-10-22 | $195.00M derived: sum of 2 quarters · filed 2020-08-07 | $247.00M derived: sum of 3 quarters · filed 2020-08-07 | $269.00M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-06-30 | $150.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $202.00M derived: sum of 2 quarters · filed 2020-08-07 | $224.00M derived: sum of 3 quarters · filed 2020-08-07 | $252.00M 10-K/A · filed 2020-08-07 |
| 2019-03-31 | $52.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-23 | $74.00M derived: sum of 2 quarters · filed 2019-04-23 | $102.00M 10-Q · filed 2019-04-23 | $236.00M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-12-31 | $22.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-23 | $50.00M 10-Q · filed 2019-01-23 | $184.00M derived: sum of 3 quarters · filed 2019-08-06 | $272.00M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-09-30 | $28.00M 10-Q · filed 2018-10-19 | $162.00M derived: sum of 2 quarters · filed 2019-08-06 | $250.00M derived: sum of 3 quarters · filed 2019-08-06 | $308.00M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-06-30 | $134.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-06 | $222.00M derived: sum of 2 quarters · filed 2019-08-06 | $280.00M derived: sum of 3 quarters · filed 2019-08-06 | $366.00M 10-K · filed 2019-08-06 |
| 2018-03-31 | $88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-19 | $146.00M derived: sum of 2 quarters · filed 2018-04-19 | $232.00M 10-Q · filed 2018-04-19 | $343.00M derived: sum of 4 quarters · filed 2018-10-22 |
| 2017-12-31 | $58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-23 | $144.00M 10-Q · filed 2018-01-23 | $255.00M derived: sum of 3 quarters · filed 2018-10-22 | $335.00M derived: sum of 4 quarters · filed 2018-10-22 |
| 2017-09-30 | $86.00M 10-Q · filed 2017-10-20 | $197.00M derived: sum of 2 quarters · filed 2018-10-22 | $277.00M derived: sum of 3 quarters · filed 2018-10-22 | $378.00M derived: sum of 4 quarters · filed 2018-10-22 |
| 2017-06-30 | $111.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-10-22 | $191.00M derived: sum of 2 quarters · filed 2018-10-22 | $292.00M derived: sum of 3 quarters · filed 2018-10-22 | $397.00M 8-K · filed 2018-10-22 |
| 2017-03-31 | $80.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-26 | $181.00M derived: sum of 2 quarters · filed 2017-04-26 | $286.00M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | $101.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-20 | $206.00M 10-Q · filed 2017-01-20 | ||
| 2016-09-30 | $105.00M 10-Q · filed 2016-10-25 | |||
| 2016-06-30 | $432.00M 10-K · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |